Emma Walmsley leads pharmaceuticals giant GlaxoSmithKline
(Picture: GSK)Only one of the 50 highest paid directorships on the boards of Britain’s most valuable blue chip companies is held by a woman, a new gender pay gap survey reveals today.
Emma Walmsley, CEO of pharmaceuticals giant GlaxoSmithKline, who earned a package worth £8.2 million last year, is the sole female representative on a FTSE 100 top pay list overwhelmingly dominated by men.
